Tag: <span>soft part sarcoma</span>

Home / soft part sarcoma
Clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma
Post

Clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma

by National Cancer Institute Left frame: Normally, tumor cells (purple) evade the immune system’s T cells (pink) by expressing a checkpoint protein known as PD-L1. Right frame: Atezolizumab (Tecentriq) binds to PD-L1 and blocks it from binding to another checkpoint protein, PD-1. This helps T cells regain their ability to kill tumor cells. Credit: Adapted...